NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ ...
Medical Device Network on MSN
Masimo secures FDA approval for OIRD detection on wearable patient monitor
The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.
Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
Stateside, the ORi sensor will be available in several of Masimo’s RD Rainbow pulse oximetry devices: a newly launched one that features four LED sensors and can calculate both oxygen saturation and ...
Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor. The adhesive TFA-1 Forehead ...
Masimo smartSET™-powered, AI-enabled OIRD detection has received FDA 510(k) clearance for the Radius VSM® wearable continuous ...
CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results